CAS Medical Systems (CASM) Posts Q2 Loss of 13c/Share

CAS Medical Systems (NASDAQ: CASM) reported Q2 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $5.8 million, versus $5 million reported last year.

For earnings history and earnings-related data on CAS Medical Systems (CASM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Diana Shipping withdraws bid to acquire Genco Shipping
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat